Teladoc Health: chief accounting officer Joseph Catapano exercised 2,083 shares

What happened Joseph Ronald Catapano, chief accounting officer, had 2,083 restricted stock units convert to 2,083 shares on Oct 1, 2026 (reported as an exercise/conversion of a derivative) and the filing also reports a disposal of 2,083 shares on Oct 1, 2026 at $0. The filing shows a sale of 655 shares on Oct 2, 2026 at $5.65 per share for total proceeds of $3,703.

Key details

• Transaction dates and prices: Oct 1, 2026 exercise/conversion of 2,083 shares (derivative) reported as acquired at N/A and disposed at $0; Oct 2, 2026 sale of 655 shares at $5.65 for $3,703.
• Shares owned after the transaction: not stated in the provided filing information.
• Footnotes from the filing:
  • F1: Restricted stock units convert to shares of TDOC common stock on a 1-for-1 basis.
  • F2: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
  • F3: On Oct 1, 2024 the reporting person was granted 25,000 restricted stock units, vesting 1/3 on the first anniversary of the grant date with the remainder vesting in eight substantially equal quarterly installments thereafter.
• Filing timeliness: not stated in the provided filing information.

Why it may matter

• The filing shows a conversion/exercise of restricted stock units into shares and a subsequent sale of some shares to cover tax withholding rather than a full cashless exercise of all acquired shares.
• The sale reported was an open-market sale for $3,703 in proceeds.
• This filing does not show why the insider traded or why the company acted.